BTG2 Antibodies

Santa Cruz Biotechnology provides a broad selection of BTG2 monoclonal antibodies for research focused on understanding BTG2 protein functions. BTG2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BTG2, or B-cell translocation gene 2, is a critical regulator of cell proliferation and differentiation, playing a significant role in tumor suppression and the modulation of immune responses. BTG2 expression is often associated with various cancers, making it an important target for therapeutic research and biomarker studies. Understanding BTG2 function can provide insights into cellular processes and potential pathways for intervention in disease. BTG2 monoclonal antibodies enable precise detection and analysis of BTG2 expression patterns across different tissue types. BTG2 monoclonal antibodies support investigation of cellular signaling pathways and regulatory mechanisms. BTG2 monoclonal antibodies from Santa Cruz Biotechnology contribute to advancing cancer research and therapeutic development within the scientific community.